Axa
OXFD

Axa’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Axa’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-479,975
Closed -$6.19M – 1414
2018
Q2 		$6.19M Sell
479,975
-100,639
-17% -$1.36M 0.02% 595
2018
Q1 		$7.23M Sell
580,614
-300,679
-34% -$3.66M 0.03% 546
2017
Q4 		$12.3M Sell
881,293
-864
-0.1% -$12.7K 0.05% 401
2017
Q3 		$14.8M Sell
882,157
-12,231
-1% -$199K 0.06% 341
2017
Q2 		$15M Sell
894,388
-23,080
-3% -$345K 0.07% 327
2017
Q1 		$14.2M Buy
917,468
+315,718
+52% +$4.51M 0.06% 339
2016
Q4 		$9M Sell
601,750
-2,053
-0.3% -$28.8K 0.04% 430
2016
Q3 		$7.58M Buy
603,803
+533
+0.1% +$5.35K 0.03% 482
2016
Q2 		$5.43M Sell
603,270
-6,609
-1% -$64.7K 0.02% 548
2016
Q1 		$6.04M Hold
609,879
– – 0.03% 510
2015
Q4 		$7.01M Sell
609,879
-801
-0.1% -$9.91K 0.03% 474
2015
Q3 		$8.24M Buy
610,680
+94,015
+18% +$1.27M 0.03% 432
2015
Q2 		$7.16M Buy
516,665
+137,061
+36% +$1.85M 0.03% 489
2015
Q1 		$5.34M Buy
379,604
+105,799
+39% +$1.44M 0.02% 580
2014
Q4 		$3.73M Buy
273,805
+17,519
+7% +$239K 0.02% 637
2014
Q3 		$3.91M Buy
256,286
+113,606
+80% +$1.74M 0.02% 594
2014
Q2 		$2.4M Buy
142,680
+65,576
+85% +$1.18M 0.01% 727
2014
Q1 		$1.55M Buy
77,104
+2,104
+3% +$45.5K 0.01% 831
2013
Q4 		$1.45M Buy
+75,000
New +$1.33M 0.01% 831

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Axa's OXFD Position: Q3 2018 in Review

Axa sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2018, closing a stake of 479,975 shares — an estimated $6.19M sold.

Axa first reported a position in OXFD in Q4 2013 and held it in 19 quarters. The position peaked at $15M in Q2 2017. 83 funds tracked by Wall St. Rank hold OXFD as of Q3 2018.

  • Axa reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2018 after selling out during the quarter.
  • Axa sold 479,975 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2018, an estimated $6.19M.
  • Axa first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 19 quarters.
  • Axa's Oxford Immunotec Global PLC Ordinary Shares position peaked at $15M in Q2 2017.
  • 83 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2018.

Based on Axa's 13F filing for Q3 2018, filed 8 Nov 2018.